Exclusive partnership will provide access for customers in China to iotaSciences proprietary single cell handling platforms based on its proprietary fluid-shaping technology
iotaSciences, the Oxford-based leader in the rapidly growing field of single-cell handling solutions, and Quantum Design China, a subsidiary of Quantum Design International, announced today an exclusive distribution agreement for iotaSciences proprietary single cell handling platforms in China.
"We are pleased to now offer customers in China access to iotaSciences platforms, which allows scientists to access highly user-friendly, reliable, and powerful single cell handling technologies and solutions with unique capabilities that greatly simplify and facilitate breakthrough advances in cell biology and gene therapy" said Lambert Cao, General Manager of Quantum Design China. "We look forward to working closely with the iotaSciences team to introduce this unique technology to the rapidly expanding field of single cell biological applications."
Ed Walsh, iotaSciences Founding Director & Chief Innovation Officer commented: "We are highly excited about this next step with Quantum Design China to see our innovative technology being deployed across the Chinese scientific community. Our proprietary fluid-shaping technology has translated very well into tangible user benefits for single-cell handling workflows as required in many frontiers research fields including CRISPR, iPSCs and gene therapy workflows."
Dr. Michael Lutz, iotaSciences recently appointed CEO added: "This partnership with Quantum Design China is another key milestone for the company´s future development path after the recent acceleration of its commercial activities leading to a doubling of its installed base in the last year. Quantum Design China is the ideal partner for us to team up with given its in-depth knowledge of optimally serving academic and industrial scientists in the life science market in China."